Form4insider filings, from the source

SEC Form 4 · accession 0001106578-26-000126

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Aug 21, 2026
Accepted (ET)
Aug 24, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Aug 21, 2026M9,500$135.42A333,943Iby Trust
Common StockF3,F2Aug 21, 2026S1,189$512.7137D332,754Iby Trust
Common StockF4,F2Aug 21, 2026S271$513.8536D332,483Iby Trust
Common StockF5,F2Aug 21, 2026S624$515.2623D331,859Iby Trust
Common StockF6,F2Aug 21, 2026S1,689$516.1496D330,170Iby Trust
Common StockF7,F2Aug 21, 2026S773$517.0696D329,397Iby Trust
Common StockF8,F2Aug 21, 2026S1,077$518.1351D328,320Iby Trust
Common StockF9,F2Aug 21, 2026S837$519.0852D327,483Iby Trust
Common StockF10,F2Aug 21, 2026S440$520.0317D327,043Iby Trust
Common StockF11,F2Aug 21, 2026S371$521.2808D326,672Iby Trust
Common StockF12,F2Aug 21, 2026S669$522.289D326,003Iby Trust
Common StockF13,F2Aug 21, 2026S455$523.6208D325,548Iby Trust
Common StockF14,F2Aug 21, 2026S625$524.3515D324,923Iby Trust
Common StockF15,F2Aug 21, 2026S235$525.4202D324,688Iby Trust
Common StockF16,F2Aug 21, 2026S45$526.4667D324,643Iby Trust
Common StockF17,F2Aug 21, 2026S200$527.708D324,443Iby Trust
Common Stockholding———40,513D
Common Stockholding———166Iby Spouse
Common StockF18holding———249,108Iby Trust
Common StockF19holding———45,596Iby Trust
Common StockF20holding———8,902Iby Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionF21$135.42Aug 21, 2026M9,500DMar 15, 2023Mar 15, 2027Common Stock9,50084,910I

Explanation of responses